For individuals with premalignant lesions that might develop into an invasive illness, secondary chemoprevention is recommended
Cell Metab 36(6):13711393e7 Chistyakov DV et al (2020) Comparison of PPAR ligands as modulators of resolution of inflammation, via their influence on cytokines and oxylipins release in astrocytes
The most common are gastrointestinal: Nausea the most frequently reported side effect, especially during dose increases Vomiting less common than nausea, but can occur during titration Diarrhea typically mild and temporary Constipation some patients experience this instead of or in addition to diarrhea Decreased appetite this is both a therapeutic effect and something patients notice as a side effect These side effects are generally most noticeable in the first few weeks of treatment or after a dose increase, and tend to improve as the body adjusts
Antioxidant and immunomodulatory action: Protects the body from oxidative stress and at the same time strengthens the immune system
PlexusDx specializes in precision GLP-1 therapy designed to match your individual response profile
Pseudolipoblastic perineurioma: An unusual morphological variant of perineurioma that may simulate liposarcoma
